Two multidrug-resistant clinical isolates of bacteroides fragilis carry a novel metronidazole resistance nim gene (nimJ)

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 8, 2013, Pages 3767-3774

  Husain, Fasahath ^a   Veeranagouda, Yaligara ^a,b   Hsi, Justin ^c   Meggersee, Rosemary ^d   Abratt, Valerie ^d   Wexler, Hannah M ^a,b  

^a GLAVAHCS   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; METRONIDAZOLE; NIM PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIUM ISOLATE; BACTEROIDES FRAGILIS; CLOSTRIDIUM BOTULINUM; CRYSTAL STRUCTURE; GENOME; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE;

ANTI-BACTERIAL AGENTS; BACTEROIDES FRAGILIS; CATALYTIC DOMAIN; CLONING, MOLECULAR; DNA PRIMERS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENES, BACTERIAL; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; PHYLOGENY; PLASMIDS; PROTEIN FOLDING; TRANSCRIPTION, GENETIC;

EID: 84880265361     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00386-13     Document Type: Article

References (51)

1. Wexler HM. 2007. Bacteroides: the Good, the Bad, and the Nitty-Gritty. Clin. Microbiol. Rev. 20:593-621.
2. Arumugam M, Raes J, Pelletier E, Le PD, Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto JM, Bertalan M, Borruel N, Casellas F, Fernandez L, Gautier L, Hansen T, Hattori M, Hayashi T, Kleerebezem M, Kurokawa K, Leclerc M, Levenez F, Manichanh C, Nielsen HB, Nielsen T, Pons N, Poulain J, Qin J, Sicheritz-Ponten T, Tims S, Torrents D, Ugarte E, Zoetendal EG, Wang J, Guarner F, Pedersen O, de Vos WM, Brunak S, Dore J, Antolin M, Artiguenave F, Blottiere HM, Almeida M, Brechot C, Cara C, Chervaux C, Cultrone A, Delorme C, Denariaz G, Dervyn R, Foerstner KU, Friss C, van de Guchte M, Guedon E, Haimet F, Huber W, van Hylckama-Vlieg J, Jamet A, Juste C, Kaci G, Knol J, Lakhdari O, Layec S, Le RK, Maguin E, Merieux A, Melo MR, M'rini C, Muller J, Oozeer R, Parkhill J, Renault P, Rescigno M, Sanchez N, Sunagawa S, Torrejon A, Turner K, Vandemeulebrouck G, Varela E, Winogradsky Y, Zeller G, Weissenbach J, Ehrlich SD, Bork P. 2011. Enterotypes of the human gut microbiome. Nature 473:174-180.
3. Qin J, Li R, Raes J, Arumugam M, Burgdorf K, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, Mende D, Li J, Xu J, Li S, Li D, Cao J, Wang B, Liang H, Zheng H, Xie Y, Tap J, Lepage P, Bertalan M, Batto JM, Hansen T, Le Paslier D, Linneberg A, Nielsen H, Pelletier E, Renault P, Sicheritz-Ponten T, Turner K, Zhu H, Yu C, Li S, Jian M, Zhou Y, Li Y, Zhang X, Li S, Qin N, Yang H, Wang J, Brunak S, Doré J, Guarner F, Kristiansen K, Pedersen O, Parkhill J, Weissenbach J, MetaHIT Consortium, Bork P, Ehrlich S, Wang J. 2010. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464:59-65.
4. Moore W, Holdeman L. 1974. Human fecal flora: the normal flora of 20 Japanese-Hawaiians. Appl. Microbiol. 75:961-979.
5. Polk BF, Kasper DL. 1977. Bacteroides fragilis subspecies in clinical isolates. Ann. Intern. Med. 86:569-571.
6. Salyers AA. 1984. Bacteroides of the human lower intestinal tract. Annu. Rev. Microbiol. 38:293-313.
7. Brook I. 2010. The role of anaerobic bacteria in bacteremia. Anaerobe 16:183-189.
8. Lofmark S, Edlund C, Nord CE. 2010. Metronidazole is still the drug of choice for treatment of anaerobic infections. Clin. Infect. Dis. 50(Suppl 1):S16-S23.
9. Pumbwe L, Wareham DW, Aduse-Opoku J, Brazier JS, Wexler HM. 2007. Genetic analysis of mechanisms of multidrug resistance in a clinical isolate of Bacteroides fragilis. Clin. Microbiol. Infect. 13:183-189.
10. Sherwood JE, Fraser S, Citron DM, Wexler HM, Blakely GW, Jobling K, Patrick S. 2011. Multi-drug resistant Bacteroides fragilis recovered from blood and severe leg wounds caused by an improvised explosive device (IED) in Afghanistan. Anaerobe 17:152-155.
11. Watt L, Jennison RF. 1960. Clinical evaluation of metronidazole: a new systemic trichomonacide. Br. Med. J. 2:902-905.
12. Knight R, Skolimowski I, Edwards D. 1978. The interaction of reduced metronidazole with DNA. Biochem. Pharmacol. 27:2089-2093.
13. Edwards D. 1993. Nitroimidazole drugs-action and resistance mechanisms. I. Mechanisms of action. J. Antimicrob. Chemother. 31:9-20.
14. Zahoor A, Lafleur M, Knight R, Loman H, Edwards D. 1987. DNA damage induced by reduced nitroimidazole drugs. Biochem. Pharmacol. 36:3299-3304.
15. Carlier J, Sellier N, Rager M, Reysset G. 1997. Metabolism of a 5-nitroimidazole in susceptible and resistant isogenic strains of Bacteroides fragilis. Antimicrob. Agents Chemother. 41:1495-1499.
16. Trinh S, Reysset G. 1996. Detection by PCR of the nim genes encoding 5-nitroimidazole resistance in Bacteroides spp. J. Clin. Microbiol. 34: 2078-2084.
17. Lofmark S, Fang H, Hedberg M, Edlund C. 2005. Inducible metronidazole resistance and nim genes in clinical Bacteroides fragilis group isolates. Antimicrob. Agents Chemother. 49:1253-1256.
18. Gal M, Brazier JS. 2004. Metronidazole resistance in Bacteroides spp. carrying nim genes and the selection of slow-growing metronidazoleresistant mutants. J. Antimicrob. Chemother. 54:109-116.
19. Alauzet C, Mory F, Teyssier C, Hallage H, Carlier JP, Grollier G, Lozniewski A. 2010. Metronidazole resistance in Prevotella spp. and description of a new nim gene in Prevotella baroniae. Antimicrob. Agents Chemother. 54:60-64.
20. Schaumann R, Petzold S, Fille M, Rodloff AC. 2005. Inducible metronidazole resistance in nim-positive and nim-negative Bacteroides fragilis group strains after several passages metronidazole containing Columbia agar plates. Infection 33:368-372.
21. Steffens L, Nicholson S, Paul L, Nord C, Patrick S, Abratt V. 2010. Bacteroides fragilis RecA protein overexpression causes resistance to metronidazole. Res. Microbiol. 161:346-354.
22. Abratt VR, Zappe H, Woods DR. 1993. A reporter gene vector to investigate the regulation of glutamine synthetase in Bacteroides fragilis Bf1. J. Gen. Microbiol. 139:59-65.
23. Pumbwe L, Chang A, Smith RL, Wexler HM. 2007. BmeRABC5 is a multidrug efflux system that can confer metronidazole resistance in Bacteroides fragilis. Microb. Drug Resist. 13:96-101.
24. Diniz CG, Farias LM, Carvalho MA, Rocha ER, Smith CJ. 2004. Differential gene expression in a Bacteroides fragilis metronidazole-resistant mutant. J. Antimicrob. Chemother. 54:100-108.
25. Wareham DW, Wilks M, Ahmed D, Brazier JS, Millar M. 2005. Anaerobic sepsis due to multidrug-resistant Bacteroides fragilis: microbiological cure and clinical response with linezolid therapy. Clin. Infect. Dis. 40:e67-e68.
26. Soki J, Fodor E, Hecht DW, Edwards R, Rotimi VO, Kerekes I, Urban E, Nagy E. 2004. Molecular characterization of imipenem-resistant, cfiApositive Bacteroides fragilis isolates from the USA, Hungary and Kuwait. J. Med. Microbiol. 53:413-419.
27. Soki J, Wareham DW, Ratkai C, Aduse-Opoku J, Urban E, Nagy E. 2010. Prevalence, nucleotide sequence and expression studies of two proteins of a 5.6kb, class III, Bacteroides plasmid frequently found in clinical isolates from European countries. Plasmid 63:86-97.
28. Pumbwe L, Ueda O, Yoshimura F, Chang A, Smith R, Wexler HM. 2006. Bacteroides fragilis BmeABC efflux systems additively confer intrinsic antimicrobial resistance. J. Antimicrob. Chemother. 58:37-46.
29. Aziz RK, Bartels D, Best AA, DeJongh M, Disz T, Edwards RA, Formsma K, Gerdes S, Glass EM, Kubal M, Meyer F, Olsen GJ, Olson R, Osterman AL, Overbeek RA, McNeil LK, Paarmann D, Paczian T, Parrello B, Pusch GD, Reich C, Stevens R, Vassieva O, Vonstein V, Wilke A, Zagnitko O. 2008. The RAST Server: rapid annotations using subsystems technology. BMC Genomics 9:75. doi:10.1186/1471- 2164-9-75.
30. Overbeek R, Begley T, Butler RM, Choudhuri JV, Chuang HY, Cohoon M, de Crecy-Lagard V, Diaz N, Disz T, Edwards R, Fonstein M, Frank ED, Gerdes S, Glass EM, Goesmann A, Hanson A, Iwata-Reuyl D, Jensen R, Jamshidi N, Krause L, Kubal M, Larsen N, Linke B, McHardy AC, Meyer F, Neuweger H, Olsen G, Olson R, Osterman A, Portnoy V, Pusch GD, Rodionov DA, Ruckert C, Steiner J, Stevens R, Thiele I, Vassieva O, Ye Y, Zagnitko O, Vonstein V. 2005. The subsystems approach to genome annotation and its use in the project to annotate 1,000 genomes. Nucleic Acids Res. 33:5691-5702.
31. Tamura KF, Peterson DF, Peterson NF, Stecher, GF, Nei MF, Kumar S. 2011. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. doi:10.1093/molbev/msr121.
32. Kelley LA, Sternberg MJ. 2009. Protein structure prediction on the Web: a case study using the Phyre server. Nat. Protoc. 4:363-371.
33. Holm L, Kaariainen S, Wilton C, Plewczynski D. 2006. Using Dali for structural comparison of proteins. Curr. Protoc. Bioinformatics Chapter 5:Unit 5.5. doi:10.1002/0471250953.bi0505s14.
34. Holm L, Kaariainen S, Rosenstrom P, Schenkel A. 2008. Searching protein structure databases with DaliLite v. 3. Bioinformatics 24:2780-2781.
35. Chatzidaki-Livanis M, Weinacht KG, Comstock LE. 2010. Trans locus inhibitors limit concomitant polysaccharide synthesis in the human gut symbiont Bacteroides fragilis. Proc. Natl. Acad. Sci. U. S. A. 107:11976-11980.
36. Guiney DG, Jr, Hasegawa P, Davis CE. 1984. Homology between clindamycin resistance plasmids in Bacteroides. Plasmid 11:268-271.
37. Veeranagouda Y, Husain F, Wexler HM. 2012. Transposon mutagenesis of the anaerobic commensal, Bacteroides fragilis, using the EZ::TN5 transposome. FEMS Microbiol. Lett. 333:94-100.
38. CLSI. 2012. Methods for antimicrobial susceptibility testing of anaerobic bacteria; approved standard, 8th ed. CLSI document M11-A8. Clinical and Laboratory Standards Institute, Wayne, PA.
39. Rosenblatt JE, Gustafson DR. 1995. Evaluation of the Etest for susceptibility testing of anaerobic bacteria. Diagn. Microbiol. Infect. Dis. 22:279-284.
40. Dereeper A, Audic S, Claverie JM, Blanc G. 2010. BLAST-EXPLORER helps you building datasets for phylogenetic analysis. BMC Evol. Biol. 10:8. doi:10.1186/1471-2148-10-8.
41. Dereeper A, Guignon V, Blanc G, Audic S, Buffet S, Chevenet F, Dufayard JF, Guindon S, Lefort V, Lescot M, Claverie JM, Gascuel O. 2008. Phylogeny.fr: robust phylogenetic analysis for the non-specialist. Nucleic Acids Res. 36:W465-W469.
42. Leiros HK, Tedesco C, McSweeney SM. 2008. High-resolution structure of the antibiotic resistance protein NimA from Deinococcus radiodurans. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 64:442-447.
43. Leiros HK, Brandsdal BO, McSweeney SM. 2010. Biophysical characterization and mutational analysis of the antibiotic resistance protein NimA from Deinococcus radiodurans. Biochim. Biophys. Acta 1804:967-976.
44. Galvao BP, Meggersee RL, Abratt VR. 2011. Antibiotic resistance and adhesion potential of Bacteroides fragilis clinical isolates from Cape Town, South Africa. Anaerobe 17:142-146.
45. Soki J, Gal M, Brazier JS, Rotimi VO, Urban E, Nagy E, Duerden BI. 2006. Molecular investigation of genetic elements contributing to metronidazole resistance in Bacteroides strains. J. Antimicrob. Chemother. 57: 212-220.
46. Reysset G, Haggoud A, Su WJ, Sebald M. 1992. Genetic and molecular analysis of pIP417 and pIP419: Bacteroides plasmids encoding 5-nitroimidazole resistance. Plasmid 27:181-190.
47. Trinh S, Haggoud A, Reysset G, Sebald M. 1995. Plasmids pIP419 and pIP421 from Bacteroides: 5-nitroimidazole resistance genes and their upstream insertion sequence elements. Microbiology 141:927-935.
48. Haggoud A, Reysset G, Azeddoug H, Sebald M. 1994. Nucleotide sequence analysis of two 5-nitroimidazole resistance determinants from Bacteroides strains and of a new insertion sequence upstream of the two genes. Antimicrob. Agents Chemother. 38:1047-1051.
49. Haggoud A, Reysset G, Sebald M. 1992. Cloning of a Bacteroides fragilis chromosomal determinant coding for 5-nitroimidazole resistance. FEMS Microbiol. Lett. 74:1-5.
50. Dubreuil L, Odou MF. 2010. Anaerobic bacteria and antibiotics: what kind of unexpected resistance could I find in my laboratory tomorrow?. Anaerobe 16:555-559.
51. Privitera GF, Dublanchet AF, Sebald M. 1979. Transfer of multiple antibiotic resistance between subspecies of Bacteroides fragilis. J. Infect. Dis. 139:97-101.